Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 76,928 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $0.37, for a total transaction of $28,463.36. Following the transaction, the director directly owned 300,283 shares of the company’s stock, valued at […]

Abeona Therapeutics Inc. (NASDAQ:ABEO – Get Free Report) SVP Brendan O’malley sold 6,305 shares of the firm’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $5.30, for a total value of $33,416.50. Following the sale, the senior vice president directly owned 440,003 shares of the company’s […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 29,749 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $0.42, for a total transaction of $12,494.58. Following the transaction, the director owned 482,776 shares of the company’s stock, valued at […]

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) COO Jeremy Chadwick sold 4,279 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $81.58, for a total value of $349,080.82. Following the completion of the sale, the chief operating officer owned 44,018 shares in […]